|
SSNA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.749640E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.198260E-02 |
| Normal-vs-Stage2 |
3.314100E-02 |
| Normal-vs-Stage3 |
4.054000E-02 |
| Normal-vs-Stage4 |
3.934600E-01 |
| Stage1-vs-Stage2 |
7.012800E-01 |
| Stage1-vs-Stage3 |
8.218000E-01 |
| Stage1-vs-Stage4 |
1.611410E-01 |
| Stage2-vs-Stage3 |
6.380600E-01 |
| Stage2-vs-Stage4 |
1.958210E-01 |
| Stage3-vs-Stage4 |
2.845600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.642460E-02 |
| Normal-vs-AfricanAmerican |
6.769200E-01 |
| Normal-vs-Asian |
4.359700E-02 |
| Caucasian-vs-AfricanAmerican |
2.235200E-01 |
| Caucasian-vs-Asian |
9.149200E-01 |
| AfricanAmerican-vs-Asian |
2.548200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.797770E-02 |
| Normal-vs-Female |
2.479600E-02 |
| Male-vs-Female |
6.150600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.005770E-02 |
| Normal-vs-Age(41-60Yrs) |
2.669700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.073030E-01 |
| Normal-vs-Age(81-100Yrs) |
7.055600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.472400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.194800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.061800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.759000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.407000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.963800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.532400E-01 |
| Classical-VS-Follicular |
6.413700E-04 |
| Classical-VS-Other |
1.152010E-01 |
| Classical-VS-Normal |
1.256600E-01 |
| Tall-VS-Follicular |
5.965500E-04 |
| Tall-VS-Other |
1.485450E-01 |
| Tall-VS-Normal |
5.733800E-01 |
| Follicular-VS-Other |
9.460800E-01 |
| Follicular-VS-Normal |
1.625530E-04 |
| Other-VS-Normal |
4.318400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.503990E-03 |
| Normal-vs-N1 |
5.198200E-02 |
| N0-vs-N1 |
4.256000E-01 |
|
|
